Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia.

Distinct patterns of DNA methylation characterize the epigenetic landscape of promyelocytic leukemia/retinoic acid receptor-α (PML-RARα)-associated acute promyelocytic leukemia (APL). We previously reported that the microRNAs (miRNAs) clustered on chromosome 14q32 are overexpressed only in APL. Here, using high-throughput bisulfite sequencing, we identified an APL-associated hypermethylation at the upstream differentially methylated region (DMR), which also included the site motifs for the enhancer blocking protein CCCTC-binding factor (CTCF). Comparing the profiles of diagnostic/remission paired patient samples, we show that hypermethylation was acquired in APL in a monoallelic manner. The cytosine guanine dinucleotide status of the DMR correlated with expression of the miRNAs following a characteristic position-dependent pattern. Moreover, a signature of hypermethylation was also detected in leukemic cells from an established transgenic PML-RARA APL mouse model at the orthologous region on chromosome 12, including the CTCF binding site located upstream from the mouse miRNA cluster. These results, together with the demonstration that the region does not show DNA methylation changes during myeloid differentiation, provide evidence that 14q32 hypermethylation is implicated in the pathogenesis of APL. We propose a model in which loss of imprinting at the 14q32 domain leads to overexpression of the miRNAs in APL.

[1]  Christine Chomienne,et al.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.

[2]  Myriam Alcalay,et al.  The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.

[3]  I. Weissman,et al.  A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  I. Weissman,et al.  A PMLRARα transgene initiates murine acute promyelocytic leukemia , 1997 .

[5]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[6]  J. Licht,et al.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. , 1999, Blood.

[7]  Jonathan D. Licht,et al.  Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .

[8]  A. West,et al.  The Protein CTCF Is Required for the Enhancer Blocking Activity of Vertebrate Insulators , 1999, Cell.

[9]  G. Pfeifer,et al.  Maternal-specific footprints at putative CTCF sites in the H19 imprinting control region give evidence for insulator function , 2000, Current Biology.

[10]  S. Murphy,et al.  Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. , 2000, Genome research.

[11]  J. Bishop,et al.  Leukemia initiated by PMLRARalpha: the PML domain plays a critical role while retinoic acid-mediated transactivation is dispensable. , 2000, Blood.

[12]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[13]  A. Ferguson-Smith,et al.  Comparative sequence analysis of the imprinted Dlk1-Gtl2 locus in three mammalian species reveals highly conserved genomic elements and refines comparison with the Igf2-H19 region. , 2001, Genome research.

[14]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[15]  S. Minucci,et al.  Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.

[16]  M. Ladanyi,et al.  Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. , 2003, Human molecular genetics.

[17]  Martina Paulsen,et al.  Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene , 2003, Nature Genetics.

[18]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[19]  David A McCormick,et al.  Neuronal Networks: Flip-Flops in theBrain , 2005, Current Biology.

[20]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[21]  V. Pant,et al.  Mutation of a Single CTCF Target Site within the H19 Imprinting Control Region Leads to Loss of Igf2 Imprinting and Complex Patterns of De Novo Methylation upon Maternal Inheritance , 2004, Molecular and Cellular Biology.

[22]  J. Cavaille,et al.  A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. , 2004, Genome research.

[23]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[24]  L. Shaffer,et al.  Allele-specific methylation of a functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32 , 2005, Chromosome Research.

[25]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[26]  P. Gregersen,et al.  Overlapping Probabilities of Top Ranking Gene Lists, Hypergeometric Distribution, and Stringency of Gene Selection Criterion , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[27]  S. Minucci,et al.  Recruitment of the Histone Methyltransferase SUV39H1 and Its Role in the Oncogenic Properties of the Leukemia-Associated PML-Retinoic Acid Receptor Fusion Protein , 2006, Molecular and Cellular Biology.

[28]  P. Jelinic,et al.  Loss of imprinting and cancer , 2007, The Journal of pathology.

[29]  T. Jenuwein,et al.  Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. , 2007, Cancer cell.

[30]  Bob Löwenberg,et al.  MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.

[31]  Sean McWilliam,et al.  Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals. , 2008, Molecular biology and evolution.

[32]  G. Behre,et al.  Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. , 2008, Blood.

[33]  Masaaki Oda,et al.  QUMA: quantification tool for methylation analysis , 2008, Nucleic Acids Res..

[34]  A. Ferguson-Smith,et al.  Genomic imprinting at the mammalian Dlk1-Dio3 domain. , 2008, Trends in genetics : TIG.

[35]  Y. Arai,et al.  Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma , 2008, British Journal of Cancer.

[36]  Martin Kircher,et al.  Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region , 2008, BMC Genomics.

[37]  Jean-Baptiste Cazier,et al.  Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia , 2008, PloS one.

[38]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[39]  A. Green,et al.  The IG-DMR and the MEG3-DMR at Human Chromosome 14q32.2: Hierarchical Interaction and Distinct Functional Properties as Imprinting Control Centers , 2010, PLoS genetics.

[40]  M. Minden,et al.  PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. , 2010, Cancer cell.

[41]  Fabien Campagne,et al.  DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. , 2010, Cancer cell.

[42]  Robert L. Judson,et al.  miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma , 2010, Nature Medicine.

[43]  Wei Li,et al.  Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells , 2010, The Journal of Biological Chemistry.

[44]  H. Stunnenberg,et al.  PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia. , 2010, Cancer cell.

[45]  E. Hatzimichael,et al.  MEG3 imprinted gene contribution in tumorigenesis , 2011, International journal of cancer.

[46]  J. Scandura,et al.  Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML. , 2011, Blood.

[47]  M. Minden,et al.  Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  P. Brousset,et al.  Specific small nucleolar RNA expression profiles in acute leukemia , 2012, Leukemia.

[49]  I. Rigoutsos,et al.  The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis , 2012, Cellular and Molecular Life Sciences.

[50]  L. Benetatos,et al.  DLK1-MEG3 imprinted domain microRNAs in cancer biology. , 2012, Critical reviews in eukaryotic gene expression.

[51]  Martin Dugas,et al.  DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding. , 2013, Blood.

[52]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.